{"id": "article-17033_0", "title": "Abetalipoproteinemia -- Continuing Education Activity", "content": "Abetalipoproteinemia is a rare autosomal recessive disorder marked by low or absent levels of plasma cholesterol, low-density lipoproteins, and very-low-density lipoproteins. It should not be confused with a deficiency in beta-lipoproteins. Hallmark symptoms include fat malabsorption, spinocerebellar degeneration, acanthocytosis, and retinitis pigmentosa. This activity reviews the etiology, epidemiology, pathophysiology, evaluation, and treatment considerations of this disease and highlights the role of the collaboration between interprofessional team members.", "contents": "Abetalipoproteinemia -- Continuing Education Activity. Abetalipoproteinemia is a rare autosomal recessive disorder marked by low or absent levels of plasma cholesterol, low-density lipoproteins, and very-low-density lipoproteins. It should not be confused with a deficiency in beta-lipoproteins. Hallmark symptoms include fat malabsorption, spinocerebellar degeneration, acanthocytosis, and retinitis pigmentosa. This activity reviews the etiology, epidemiology, pathophysiology, evaluation, and treatment considerations of this disease and highlights the role of the collaboration between interprofessional team members."}
{"id": "article-17033_1", "title": "Abetalipoproteinemia -- Continuing Education Activity", "content": "Objectives: Explain how abetalipoproteinemia manifests in each of the three main organ systems that it affects. Describe anticipated laboratory findings of a patient with abetalipoproteinemia. Outline the treatment of abetalipoproteinemia. Review the importance of collaboration between interprofessional team members for improved recognition and treatment of abetalipoproteinemia. Access free multiple choice questions on this topic.", "contents": "Abetalipoproteinemia -- Continuing Education Activity. Objectives: Explain how abetalipoproteinemia manifests in each of the three main organ systems that it affects. Describe anticipated laboratory findings of a patient with abetalipoproteinemia. Outline the treatment of abetalipoproteinemia. Review the importance of collaboration between interprofessional team members for improved recognition and treatment of abetalipoproteinemia. Access free multiple choice questions on this topic."}
{"id": "article-17033_2", "title": "Abetalipoproteinemia -- Introduction", "content": "Abetalipoproteinemia (ABL)\u00a0is a rare autosomal recessive disorder marked by low or absent levels of plasma cholesterol, low-density lipoproteins (LDLs), and very-low-density lipoproteins (VLDLs). It should not be confused with a deficiency in beta-lipoproteins. Hallmark symptoms include\u00a0fat malabsorption, spinocerebellar degeneration, acanthocyte red blood cells, and retinitis pigmentosa. [1] [2] Treatment aims to arrest the neuropathy and efficiency-induced complications in patients.", "contents": "Abetalipoproteinemia -- Introduction. Abetalipoproteinemia (ABL)\u00a0is a rare autosomal recessive disorder marked by low or absent levels of plasma cholesterol, low-density lipoproteins (LDLs), and very-low-density lipoproteins (VLDLs). It should not be confused with a deficiency in beta-lipoproteins. Hallmark symptoms include\u00a0fat malabsorption, spinocerebellar degeneration, acanthocyte red blood cells, and retinitis pigmentosa. [1] [2] Treatment aims to arrest the neuropathy and efficiency-induced complications in patients."}
{"id": "article-17033_3", "title": "Abetalipoproteinemia -- Etiology", "content": "Abetalipoproteinemia is caused by a homozygous autosomal recessive mutation in the MTTP gene. More than 33 mutations that cause the disease have been identified. The gene codes for microsomal triglyceride protein\u00a0(MTP) that mediates intracellular chylomicron or VLDL assembly and transport in the intestinal mucosa and hepatocytes.\u00a0Most of the signs and symptoms of the disease result from a severe deficiency of fats and fat-soluble vitamins, especially vitamin E. It usually presents in infants as failure to thrive, steatorrhea, and abdominal distension and results in spinocerebellar degeneration and retinitis pigmentosa. [3]", "contents": "Abetalipoproteinemia -- Etiology. Abetalipoproteinemia is caused by a homozygous autosomal recessive mutation in the MTTP gene. More than 33 mutations that cause the disease have been identified. The gene codes for microsomal triglyceride protein\u00a0(MTP) that mediates intracellular chylomicron or VLDL assembly and transport in the intestinal mucosa and hepatocytes.\u00a0Most of the signs and symptoms of the disease result from a severe deficiency of fats and fat-soluble vitamins, especially vitamin E. It usually presents in infants as failure to thrive, steatorrhea, and abdominal distension and results in spinocerebellar degeneration and retinitis pigmentosa. [3]"}
{"id": "article-17033_4", "title": "Abetalipoproteinemia -- Epidemiology", "content": "Abetalipoproteinemia occurs in less than 1 in 1 million persons. Consanguineous marriages are strongly implicated. Because it is autosomal recessive,\u00a0both copies of the gene must be faulty to cause the disease. It occurs\u00a0in females and males equally. [4]", "contents": "Abetalipoproteinemia -- Epidemiology. Abetalipoproteinemia occurs in less than 1 in 1 million persons. Consanguineous marriages are strongly implicated. Because it is autosomal recessive,\u00a0both copies of the gene must be faulty to cause the disease. It occurs\u00a0in females and males equally. [4]"}
{"id": "article-17033_5", "title": "Abetalipoproteinemia -- Epidemiology", "content": "One particular mutation is more common in people of Ashkenazi (eastern and central European) Jewish descent. This mutation substitutes the protein building block, or amino acid, glycine with a stop signal at position 865 (written as Gly865X or G865X). As a result of this amino acid change, an abnormally small, nonfunctional version of the protein is made. [5]", "contents": "Abetalipoproteinemia -- Epidemiology. One particular mutation is more common in people of Ashkenazi (eastern and central European) Jewish descent. This mutation substitutes the protein building block, or amino acid, glycine with a stop signal at position 865 (written as Gly865X or G865X). As a result of this amino acid change, an abnormally small, nonfunctional version of the protein is made. [5]"}
{"id": "article-17033_6", "title": "Abetalipoproteinemia -- Pathophysiology", "content": "Beta apolipoproteins are very large apolipoproteins. They are critically important for the secretion and formation of chylomicrons (CMs) and VLDL. Abnormalities that impede this process result in abetalipoproteinemia and hypobetalipoproteinemia. [6] [7] [8]", "contents": "Abetalipoproteinemia -- Pathophysiology. Beta apolipoproteins are very large apolipoproteins. They are critically important for the secretion and formation of chylomicrons (CMs) and VLDL. Abnormalities that impede this process result in abetalipoproteinemia and hypobetalipoproteinemia. [6] [7] [8]"}
{"id": "article-17033_7", "title": "Abetalipoproteinemia -- Pathophysiology", "content": "MTP acts as a chaperone that facilitates the transfer of lipids onto apo B. MTP is found within the lumen of microsomes in the liver and intestinal mucosa and\u00a0catalyzes the transfer of triglyceride, cholesteryl esters, and phosphatidylcholine between membranes.\u00a0Lipid transport rates decrease in the order of triglyceride to cholesteryl ester to diglyceride to cholesterol to phosphatidylcholine. Unlike other lipid transfer proteins, MTP is a heterodimer containing subunits of molecular mass 58 and 97 kDa. The large 97-kDa subunit possesses the lipid transfer activity or confers lipid transfer activity on the complex. The large subunit of MTP may be missing in abetalipoproteinemia.", "contents": "Abetalipoproteinemia -- Pathophysiology. MTP acts as a chaperone that facilitates the transfer of lipids onto apo B. MTP is found within the lumen of microsomes in the liver and intestinal mucosa and\u00a0catalyzes the transfer of triglyceride, cholesteryl esters, and phosphatidylcholine between membranes.\u00a0Lipid transport rates decrease in the order of triglyceride to cholesteryl ester to diglyceride to cholesterol to phosphatidylcholine. Unlike other lipid transfer proteins, MTP is a heterodimer containing subunits of molecular mass 58 and 97 kDa. The large 97-kDa subunit possesses the lipid transfer activity or confers lipid transfer activity on the complex. The large subunit of MTP may be missing in abetalipoproteinemia."}
{"id": "article-17033_8", "title": "Abetalipoproteinemia -- Pathophysiology", "content": "Initial assembly occurs in the endoplasmic reticulum, where apolipoproteins, cholesterol, phospholipid, and triacylglycerides are synthesized and incorporated into lipoprotein particles. The particles are subsequently transported to Golgi and secreted.\u00a0Each lipoprotein is specific in its lipid composition and the type of apolipoproteins it possesses.", "contents": "Abetalipoproteinemia -- Pathophysiology. Initial assembly occurs in the endoplasmic reticulum, where apolipoproteins, cholesterol, phospholipid, and triacylglycerides are synthesized and incorporated into lipoprotein particles. The particles are subsequently transported to Golgi and secreted.\u00a0Each lipoprotein is specific in its lipid composition and the type of apolipoproteins it possesses."}
{"id": "article-17033_9", "title": "Abetalipoproteinemia -- Pathophysiology", "content": "The two beta apolipoproteins are B-100 and B-48. ApoB-100 is carried on VLDL. ApoB-100, synthesized by the liver, is larger than apoB-48, which is made up of 4536 amino acids. Unlike apoB-48, apoB-100 contains the binding site essential for LDL uptake by hepatocyte LDL receptors. ApoB-48 is carried on CMs and is derived from the same gene as apoB-100. [1]", "contents": "Abetalipoproteinemia -- Pathophysiology. The two beta apolipoproteins are B-100 and B-48. ApoB-100 is carried on VLDL. ApoB-100, synthesized by the liver, is larger than apoB-48, which is made up of 4536 amino acids. Unlike apoB-48, apoB-100 contains the binding site essential for LDL uptake by hepatocyte LDL receptors. ApoB-48 is carried on CMs and is derived from the same gene as apoB-100. [1]"}
{"id": "article-17033_10", "title": "Abetalipoproteinemia -- Pathophysiology -- Gastrointestinal Manifestations", "content": "These manifestations include diarrhea and fat-soluble vitamin deficiency. They are evident from infancy.\u00a0Diarrhea may not be a prominent symptom later, though, because patients learn to avoid fatty foods. However, the\u00a0deficits in\u00a0fat-soluble vitamins continue because their assimilation and transport depend heavily on\u00a0the integrity of the\u00a0apoB pathway. It is worth noting that high-dose vitamin E supplementation only results in marginally increased serum vitamin levels. In contrast,\u00a0high doses of vitamin-A therapy can achieve normal serum levels. This shows that despite the damaged intestinal\u00a0absorption, the transport of vitamin A by retinol-binding proteins in serum is not impaired in abetalipoproteinemia.", "contents": "Abetalipoproteinemia -- Pathophysiology -- Gastrointestinal Manifestations. These manifestations include diarrhea and fat-soluble vitamin deficiency. They are evident from infancy.\u00a0Diarrhea may not be a prominent symptom later, though, because patients learn to avoid fatty foods. However, the\u00a0deficits in\u00a0fat-soluble vitamins continue because their assimilation and transport depend heavily on\u00a0the integrity of the\u00a0apoB pathway. It is worth noting that high-dose vitamin E supplementation only results in marginally increased serum vitamin levels. In contrast,\u00a0high doses of vitamin-A therapy can achieve normal serum levels. This shows that despite the damaged intestinal\u00a0absorption, the transport of vitamin A by retinol-binding proteins in serum is not impaired in abetalipoproteinemia."}
{"id": "article-17033_11", "title": "Abetalipoproteinemia -- Pathophysiology -- Hepatic Manifestations", "content": "Hepatomegaly due to hepatic steatosis. Possible increase in serum ALTs and ASTs Reports of cirrhosis\u00a0in some patients", "contents": "Abetalipoproteinemia -- Pathophysiology -- Hepatic Manifestations. Hepatomegaly due to hepatic steatosis. Possible increase in serum ALTs and ASTs Reports of cirrhosis\u00a0in some patients"}
{"id": "article-17033_12", "title": "Abetalipoproteinemia -- Pathophysiology -- Hematologic Manifestations", "content": "Acanthocytosis is a hallmark feature of this disease. Acanthocytes are abnormally spiked RBCs due to the defective phospholipid cell membrane. They are also seen in liver dysfunction. Because of their inability to form rouleaux, erythrocyte sedimentation rates could be very\u00a0low. Fat malabsorption could lead to deficiencies in iron, and folic acid, among others, and lead to anemia. Vitamin E is involved in protection from free radical damage. Its deficiency could potentiate lipid peroxidation of cells and lead to hemolysis. This exacerbates anemia. Vitamin K is involved in the gamma decarboxylation of clotting factors, an indispensable step in coagulation. Its deficiency could lead to bleeding disorders.", "contents": "Abetalipoproteinemia -- Pathophysiology -- Hematologic Manifestations. Acanthocytosis is a hallmark feature of this disease. Acanthocytes are abnormally spiked RBCs due to the defective phospholipid cell membrane. They are also seen in liver dysfunction. Because of their inability to form rouleaux, erythrocyte sedimentation rates could be very\u00a0low. Fat malabsorption could lead to deficiencies in iron, and folic acid, among others, and lead to anemia. Vitamin E is involved in protection from free radical damage. Its deficiency could potentiate lipid peroxidation of cells and lead to hemolysis. This exacerbates anemia. Vitamin K is involved in the gamma decarboxylation of clotting factors, an indispensable step in coagulation. Its deficiency could lead to bleeding disorders."}
{"id": "article-17033_13", "title": "Abetalipoproteinemia -- Pathophysiology -- Neurological Involvement", "content": "Peripheral neuropathy, delayed intellectual development, tremor, nystagmus, loss of deep tendon reflexes", "contents": "Abetalipoproteinemia -- Pathophysiology -- Neurological Involvement. Peripheral neuropathy, delayed intellectual development, tremor, nystagmus, loss of deep tendon reflexes"}
{"id": "article-17033_14", "title": "Abetalipoproteinemia -- Pathophysiology -- Neurological Involvement", "content": "These may be myriad and variable in their severity. The primary pathophysiology is demyelination due to deficiency of lipid-soluble vitamins. The central and peripheral nervous systems are both affected.", "contents": "Abetalipoproteinemia -- Pathophysiology -- Neurological Involvement. These may be myriad and variable in their severity. The primary pathophysiology is demyelination due to deficiency of lipid-soluble vitamins. The central and peripheral nervous systems are both affected."}
{"id": "article-17033_15", "title": "Abetalipoproteinemia -- Pathophysiology -- Muscle Involvement", "content": "Weakness and increased degeneration", "contents": "Abetalipoproteinemia -- Pathophysiology -- Muscle Involvement. Weakness and increased degeneration"}
{"id": "article-17033_16", "title": "Abetalipoproteinemia -- Pathophysiology -- Ophthalmic Involvement", "content": "Retinitis pigmentosa, decreased night and color vision, blindness", "contents": "Abetalipoproteinemia -- Pathophysiology -- Ophthalmic Involvement. Retinitis pigmentosa, decreased night and color vision, blindness"}
{"id": "article-17033_17", "title": "Abetalipoproteinemia -- Histopathology", "content": "Acanthocytes on the peripheral blood smear are seen in\u00a0abetalipoproteinemia.", "contents": "Abetalipoproteinemia -- Histopathology. Acanthocytes on the peripheral blood smear are seen in\u00a0abetalipoproteinemia."}
{"id": "article-17033_18", "title": "Abetalipoproteinemia -- History and Physical", "content": "Failure to thrive in infancy may cause gastroenterologic, neurologic, and ophthalmologic\u00a0symptoms, including\u00a0the following:", "contents": "Abetalipoproteinemia -- History and Physical. Failure to thrive in infancy may cause gastroenterologic, neurologic, and ophthalmologic\u00a0symptoms, including\u00a0the following:"}
{"id": "article-17033_19", "title": "Abetalipoproteinemia -- History and Physical -- Gastroenterology Symptoms", "content": "Steatorrhea and diarrhea Abdominal distension", "contents": "Abetalipoproteinemia -- History and Physical -- Gastroenterology Symptoms. Steatorrhea and diarrhea Abdominal distension"}
{"id": "article-17033_20", "title": "Abetalipoproteinemia -- History and Physical -- Neurologic Symptoms", "content": "Slow mental growth Deep tendon reflexes are absent Ataxia Slurred speech Peripheral neuropathy. Intention tremors.", "contents": "Abetalipoproteinemia -- History and Physical -- Neurologic Symptoms. Slow mental growth Deep tendon reflexes are absent Ataxia Slurred speech Peripheral neuropathy. Intention tremors."}
{"id": "article-17033_21", "title": "Abetalipoproteinemia -- History and Physical -- Ophthalmologic Symptoms", "content": "Retinitis pigmentosa\u00a0by adolescence (due to deficiency of vitamin A) Decreased night and color vision. Blindness may occur", "contents": "Abetalipoproteinemia -- History and Physical -- Ophthalmologic Symptoms. Retinitis pigmentosa\u00a0by adolescence (due to deficiency of vitamin A) Decreased night and color vision. Blindness may occur"}
{"id": "article-17033_22", "title": "Abetalipoproteinemia -- Evaluation -- Complete Blood Count", "content": "Complete blood count shows anemia, thrombocytopenia, or pancytopenia. [1]", "contents": "Abetalipoproteinemia -- Evaluation -- Complete Blood Count. Complete blood count shows anemia, thrombocytopenia, or pancytopenia. [1]"}
{"id": "article-17033_23", "title": "Abetalipoproteinemia -- Evaluation -- Blood Smear", "content": "Blood smear shows acanthocytes (Burr cells).", "contents": "Abetalipoproteinemia -- Evaluation -- Blood Smear. Blood smear shows acanthocytes (Burr cells)."}
{"id": "article-17033_24", "title": "Abetalipoproteinemia -- Evaluation -- Fasting Lipid Profile", "content": "Fasting lipid profile shows low VLDLs, LDLs, and total cholesterol.", "contents": "Abetalipoproteinemia -- Evaluation -- Fasting Lipid Profile. Fasting lipid profile shows low VLDLs, LDLs, and total cholesterol."}
{"id": "article-17033_25", "title": "Abetalipoproteinemia -- Evaluation -- Stool Study", "content": "Stool studies show fat malabsorption and the absence of evidence for other possible\u00a0causes.", "contents": "Abetalipoproteinemia -- Evaluation -- Stool Study. Stool studies show fat malabsorption and the absence of evidence for other possible\u00a0causes."}
{"id": "article-17033_26", "title": "Abetalipoproteinemia -- Evaluation -- Imaging Studies", "content": "Hepatic scan or ultrasonography to assess changes of fatty liver Magnetic resonance imaging (MRI) of the spinocerebellar region may show degeneration Eye and retinal examination and imaging to check for retinal damage", "contents": "Abetalipoproteinemia -- Evaluation -- Imaging Studies. Hepatic scan or ultrasonography to assess changes of fatty liver Magnetic resonance imaging (MRI) of the spinocerebellar region may show degeneration Eye and retinal examination and imaging to check for retinal damage"}
{"id": "article-17033_27", "title": "Abetalipoproteinemia -- Treatment / Management", "content": "Dietary Manipulation [9] Strict restriction of long-chain fatty acids Vitamin Supplementation Very large doses of oral vitamin E Vitamin A supplementation is instituted if an elevated prothrombin time suggests vitamin K depletion. Physiotherapy Occupational Therapy", "contents": "Abetalipoproteinemia -- Treatment / Management. Dietary Manipulation [9] Strict restriction of long-chain fatty acids Vitamin Supplementation Very large doses of oral vitamin E Vitamin A supplementation is instituted if an elevated prothrombin time suggests vitamin K depletion. Physiotherapy Occupational Therapy"}
{"id": "article-17033_28", "title": "Abetalipoproteinemia -- Differential Diagnosis", "content": "Chronic cholestatic liver disease Combined neuropathy and ataxia Familial vitamin E deficiency Hereditary sensorimotor neuropathies\u00b7 Retinal degeneration Secondary cancers Spinocerebellar disorders", "contents": "Abetalipoproteinemia -- Differential Diagnosis. Chronic cholestatic liver disease Combined neuropathy and ataxia Familial vitamin E deficiency Hereditary sensorimotor neuropathies\u00b7 Retinal degeneration Secondary cancers Spinocerebellar disorders"}
{"id": "article-17033_29", "title": "Abetalipoproteinemia -- Prognosis -- Prognostic Factors", "content": "Age at diagnosis The onset of treatment with a low-fat diet and vitamin replacement therapy Type of MTP mutation and APOE genotype with the long-term outcome of patients with abetalipoproteinemia", "contents": "Abetalipoproteinemia -- Prognosis -- Prognostic Factors. Age at diagnosis The onset of treatment with a low-fat diet and vitamin replacement therapy Type of MTP mutation and APOE genotype with the long-term outcome of patients with abetalipoproteinemia"}
{"id": "article-17033_30", "title": "Abetalipoproteinemia -- Enhancing Healthcare Team Outcomes", "content": "Abetalipoproteinemia is a relatively rare genetic and acquired disorder that is characterized by acanthocytic red blood cells, fat malabsorption, spinocerebellar degeneration, and pigmented retinopathy. The condition is associated with very high morbidity, and thus it is vital to have an integrated pathway of management with close interaction with a number of health professionals. Besides a gastroenterologist, an interprofessional approach is essential if one is to improve outcomes:", "contents": "Abetalipoproteinemia -- Enhancing Healthcare Team Outcomes. Abetalipoproteinemia is a relatively rare genetic and acquired disorder that is characterized by acanthocytic red blood cells, fat malabsorption, spinocerebellar degeneration, and pigmented retinopathy. The condition is associated with very high morbidity, and thus it is vital to have an integrated pathway of management with close interaction with a number of health professionals. Besides a gastroenterologist, an interprofessional approach is essential if one is to improve outcomes:"}
{"id": "article-17033_31", "title": "Abetalipoproteinemia -- Enhancing Healthcare Team Outcomes", "content": "Ophthalmologist to regularly assess for retinal degeneration and ophthalmoplegia Internist to assess the cholesterol profile and the abetalipoproteinemia. Neurologist: to assess and monitor the patient for spinocerebellar degeneration Hematologist to assess the anemia and acanthocytosis Pharmacist to determine the need for pyridoxine and total parenteral nutrition or supplementation with vitamins Dietitian to assess the patient for failure to thrive, assess malabsorption of fat-soluble vitamins, and the need to change diet Genetic counseling for patients and their first-degree relatives Social worker and nurse to assess the patients for nutritional needs, failure to thrive, and referral to a specialist.", "contents": "Abetalipoproteinemia -- Enhancing Healthcare Team Outcomes. Ophthalmologist to regularly assess for retinal degeneration and ophthalmoplegia Internist to assess the cholesterol profile and the abetalipoproteinemia. Neurologist: to assess and monitor the patient for spinocerebellar degeneration Hematologist to assess the anemia and acanthocytosis Pharmacist to determine the need for pyridoxine and total parenteral nutrition or supplementation with vitamins Dietitian to assess the patient for failure to thrive, assess malabsorption of fat-soluble vitamins, and the need to change diet Genetic counseling for patients and their first-degree relatives Social worker and nurse to assess the patients for nutritional needs, failure to thrive, and referral to a specialist."}
{"id": "article-17033_32", "title": "Abetalipoproteinemia -- Enhancing Healthcare Team Outcomes -- Evidence-based Medicine", "content": "Because of the rarity of the disorder, there is a lack of randomized clinical trials on the long-term benefits of vitamins. However, small case series and anecdotal reports indicate that when patients are diagnosed and referred early to a clinic that specializes in the management of this lipid disorder, the outcomes are improved. [10] There is ample evidence indicating that prompt supplementation with vitamins can improve the prognosis and outcome. [11] [Level 3] However, the long-term outlook for many of these patients is guarded as many go on to\u00a0develop vision loss and permanent blindness.", "contents": "Abetalipoproteinemia -- Enhancing Healthcare Team Outcomes -- Evidence-based Medicine. Because of the rarity of the disorder, there is a lack of randomized clinical trials on the long-term benefits of vitamins. However, small case series and anecdotal reports indicate that when patients are diagnosed and referred early to a clinic that specializes in the management of this lipid disorder, the outcomes are improved. [10] There is ample evidence indicating that prompt supplementation with vitamins can improve the prognosis and outcome. [11] [Level 3] However, the long-term outlook for many of these patients is guarded as many go on to\u00a0develop vision loss and permanent blindness."}
{"id": "article-17033_33", "title": "Abetalipoproteinemia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Abetalipoproteinemia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}